Wednesday, April 19, 2017

Equity Trader Alert #2017 - 84
(UPDATED) Information Regarding Reverse Merger and Business Combination between Dipexium Pharmaceuticals, Inc. (DPRX) and PLx Pharma Inc.

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Resources:


The reverse merger and business combination of Dipexium Pharmaceuticals, Inc. and PLx Pharma Inc. became effective today, Wednesday, April 19, 2017. Dipexium Pharmaceuticals, Inc. (DPRX) will undergo a one-for-eight (1-8) reverse stock split, a change of name, a change of symbol, and a new CUSIP number. The details are as follows:

Old Company Name: Dipexium Pharmaceuticals, Inc.
Issue: Common Stock
Old CUSIP: 25456J104
Old Symbol: DPRX
New Company Name: PLx Pharma Inc.
New CUSIP: 72942A107
New Symbol: PLXP
Ratio of Reverse Split: 1 for 8
Marketplace Effective Date: April 20, 2017

For information regarding this announcement, contact Nasdaq Corporate Data Operations at +1 877 308 0523.

If you would like to register as a market maker in PLXP, contact Nasdaq Trading Services at +1 212 231 5100.

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit: business.nasdaq.com.